Progenitor Cell Therapy in a Porcine Acute Myocardial Infarction Model Induces Cardiac Hypertrophy, Mediated by Paracrine Secretion of Cardiotrophic Factors Including TGFβ1
Authors:
- 1 October 2008
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 17 (5) , 941-952
Abstract
Administration of endothelial progenitor cells (EPC) is a promising therapy for post-infarction cardiac repair. However, the mechanisms that underlie apparent beneficial effects on myocardial remodeling are unclear. In a porcine model of acute myocardial infarction, we investigated the therapeutic effects of a mixed population of culture modified peripheral blood mononuclear cells (termed hereafter porcine EPC). Porcine EPC were isolated using methods identical to those previously adopted for harvest of EPC in human cell therapy studies. In addition the therapeutic effects of paracrine factors secreted by these cells was evaluated in vitro and in vivo. Intracoronary injection of autologous porcine EPC was associated with increased infarct territory mass and improved regional ventricular systolic function at 2 months compared to control. Treatment with conditioned media derived from autologous EPC was associated with similar improved effects on infarct territory mass and function. Histologic analysis of the infarct territory revealed significantly increased cardiomyocyte size in EPC and conditioned media treated groups, when compared to controls. A paracrine EPC effect was also verified in a pure myocardial preparation in which cardiomyocytes devoid of fibroblast, neuronal and vascular elements directly responded by increasing cell mass when exposed to the same conditioned media. Analysis of conditioned media revealed elevated levels of TGFβ1 (human 267.3±11.8 pg/ml, porcine 57.1±6.1 pg/ml), a recognized mediator of hypertrophic signaling in the heart. Neutralizing antibodies to TGFβ1 attenuated the pro-hypertrophic effect of conditioned media, and use of recombinant TGFβ1 added to fresh media replicated the pro-hypertrophic effects of conditioned media in vitro. These data demonstrate the potential of paracrine factors secreted from endothelial progenitor cells to induce cardiomyocyte hypertrophy contributing to increased infarct territory LV mass, with favorable medium term effects on regional function following myocardial infarction.Keywords
This publication has 50 references indexed in Scilit:
- Activation of TGF-β1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- TGF-β1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activationJournal of Molecular and Cellular Cardiology, 2005
- Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failureJournal of Clinical Investigation, 2005
- Yin and Yang of Myocardial Transforming Growth Factor-β 1Circulation, 2005
- Vascular Progenitor Cells: Origin and Mechanisms of Mobilization, Differentiation, Integration, and VasculogenesisStem Cells and Development, 2005
- Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes modelJACC, 2004
- Fibroblast growth factor-2 mediates pressure-induced hypertrophic responseJournal of Clinical Investigation, 1999
- Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β1 and endothelin-1 from fibroblastsCardiovascular Research, 1998
- Editorial: Is Tissue Mass Regulated by Vascular Endothelial Cells? Prostate as the First EvidenceEndocrinology, 1998
- Temporal and spatial development of infarcts in porcine heartsBasic Research in Cardiology, 1984